Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov;65(11):1427-32.
doi: 10.1136/ard.2006.054304. Epub 2006 May 17.

A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients

L Federici  1 , C Rittore-Domingo, I Koné-Paut, C Jorgensen, M Rodière, A Le Quellec, I Touitou
Affiliations

A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients

L Federici et al. Ann Rheum Dis. 2006 Nov.

Abstract

Background: The diagnostic value of molecular analysis of the familial Mediterranean fever (FMF) gene (Mediterranean fever (MEFV)) has been well established only in patients selected on the basis of ethnic background or clinical criteria. Genetic diagnosis for other hereditary periodic fever syndromes has been poorly evaluated.

Objective: To determine the diagnostic contribution of genetic tests for hereditary periodic syndromes in a large, unselected series of patients.

Methods: A retrospective study was conducted on 1941 patients referred to us for FMF genetic tests between 1997 and 2005. MEFV genotypes were compared with clinical data to appraise criteria for FMF diagnosis. Genetic tests for tumour necrosis factor receptor-associated periodic syndrome (TRAPS), hyperimmunoglobulinaemia D syndrome (HIDS) and cryopyrin-associated periodic syndromes (CAPS) were also reviewed.

Results: 71% of the 1574 patients with enough data had a clinical diagnosis of FMF according to the widely used Israeli criteria. Two MEFV mutations were found in only 409 patients of this subgroup (sensitivity = 37%) and in 15 (3.3%) of the patients with an improbable clinical diagnosis of FMF (specificity = 97%). Molecular diagnosis for alternate hereditary periodic syndromes was carried out in 456 of the patients having a non-conclusive FMF genetic test. A positive diagnosis was obtained in 31 of these patients (TRAPS (n = 19), HIDS (n = 4) and CAPS (n = 8)).

Conclusions: First-line MEFV mutation screening in patients with clinically typical FMF may be appropriate only in particular areas. To optimise genetic diagnosis, we propose a decision tree, which, with the advice of an expert practitioner, could help redirect test indications towards non-FMF hereditary periodic syndromes.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Ben‐Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998351659–664. - PubMed
    1. Samuels J, Aksentijevich I, Torosyan Y, Centola M, Deng Z, Sood R.et al Familial Mediterranean fever at the millenium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 199877268–297. - PubMed
    1. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 19863141001–1005. - PubMed
    1. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T.et al Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997401879–1885. - PubMed
    1. The French FMF Consortium A candidate gene for familial Mediterranean fever. Nat Genet 19971725–31. - PubMed

Publication types